The Surgical Management of Brain Metastases in Non-Small Cell Lung Cancer (NSCLC): Identification of the Early Laboratory and Clinical Determinants of Survival.
Matthias SchneiderNiklas SchäferChristian BodeLars EichhornFrank A GiordanoErdem GüresirMuriel HeimannYon-Dschun KoJennifer LandsbergFelix LehmannAlexander RadbruchChristina SchaubKatjana S SchwabJohannes WellerUlrich HerrlingerHartmut VatterPatrick SchussPublished in: Journal of clinical medicine (2021)
The present study identified several predictors for a worsened OS in patients that underwent surgery for BM of NSCLC. These findings might guide a better risk/benefit assessment in the course of metastatic NSCLC therapy and might help to more sufficiently cope with the challenges of cancer therapy in these advanced stages of disease.
Keyphrases
- small cell lung cancer
- brain metastases
- cancer therapy
- end stage renal disease
- advanced non small cell lung cancer
- newly diagnosed
- minimally invasive
- squamous cell carcinoma
- ejection fraction
- chronic kidney disease
- drug delivery
- prognostic factors
- stem cells
- bone marrow
- coronary artery bypass
- atrial fibrillation
- patient reported
- cell therapy
- surgical site infection
- bioinformatics analysis
- tyrosine kinase